Full Text
Full text is available in PDF
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
Author(s):
1Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Published online:Nov 22, 2014
Article type:Editorial
Received:Nov 21, 2014
Accepted:Nov 22, 2014
How to Cite:Pourhoseingholi M A, Ashtari S, Alavian S M. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?.Hepat Mon.2014;14(11):25540.https://doi.org/10.5812/hepatmon.25540.
Abstract
Copyright
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Crossmark
Checking
Comments
Number of Comments:0Cited by
Purchasing Reprints
- Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations
Author(s):
Related Articles